Melinda Kimmel
Adult Health · Aurora, CONPI 1437779709
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,255 of the $2,935 with a category attached, or 76.8%. 14 manufacturers reported payments, led by Medtronic at 39.7% of the total. Reporting peaked in 2023 at $1,467 and has fallen 88.5% since, to $168 in 2025.
Across 54 payments — averaging $54.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Neurocrine Biosciences, Inc.$395
- Biohaven Pharmaceutical Holding Company Ltd.$241
- AbbVie$214
- AstraZeneca$159
- Exact Sciences$149
- plus $612 from 8 others
What the payments were for
- Travel & lodging$68023%
- Food & beverage$2,25577%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 12 | $1,164 |
| Neurocrine Biosciences, Inc. | 4 | $395 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $241 |
| AbbVie(2 entities) | 15 | $214 |
| AstraZeneca | 1 | $159 |
| Exact Sciences | 1 | $149 |
| Amgen | 1 | $143 |
| Hologic Sales And Service, LLC | 1 | $135 |
| Idorsia Pharmaceuticals US Inc | 1 | $104 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $92 |
| Sandoz | 2 | $54 |
| Novartis | 1 | $34 |
| EMD Serono, Inc. | 1 | $31 |
| Genentech, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$771
- INGREZZA$234
- Strensiq$159
- The Cologuard Plus Collection Kit$149
- KRYSTEXXA$143
- Aptima$135
- NURTEC ODT$125
- QUVIVIQ$104
How this compares
$2,935 in reported general payments places this provider in the 85th percentile of 430 adult health providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Kesimpta PenOfatumumab | 19 | $155,849 |
| Dalfampridine ErDalfampridine | 51 | $37,278 |
| Baclofen | 56 | $1,681 |
| Gabapentin | 23 | $1,446 |
| Modafinil | 14 | $558 |
| Duloxetine Hcl | 11 | $319 |
Paid to pharmacies, not to this prescriber.
Other adult health in Aurora
- Stefanie EymarAurora$36K
- Alexandra GravesAurora$18K
- Keri HalsemaAurora$17K
- Grace WorlandAurora$11K
- Glen PetersonAurora$8K
- Amber KohlerAurora$6K
- Kimberly NdahayoAurora$5K
- Susan EstesAurora$5K
- Aparna GuptaAurora$5K
- Ann PereiraAurora$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.